Return to search

Použití agonistů FPR receptorů pro terapii nádorových onemocnění / The use of agonists of formyl peptide receptors for cancer therapy

The main goal of the thesis was to optimize the use of agonists of the FPR receptors for cancer therapy. The aim was: (1) to find the best anchor of ligands to the cancer cells and the optimal timing of the treatment, (2) to verify the universality of agonists of FPR receptors for different types of cancer, (3) to explain the synergy between ligands of FPR and ligands of TLR by flow cytometry and (4) to verify the applicability of cytotoxic test CD45+/ PI for f-MLF-DOPE ligand.

Identiferoai:union.ndltd.org:nusl.cz/oai:invenio.nusl.cz:166166
Date January 2013
CreatorsCAISOVÁ, Veronika
Source SetsCzech ETDs
LanguageCzech
Detected LanguageEnglish
Typeinfo:eu-repo/semantics/masterThesis
Rightsinfo:eu-repo/semantics/restrictedAccess

Page generated in 0.0017 seconds